by TractManager | Aug 26, 2020 | Health Technology Assessment
Focus of the Report: This report focuses on matrix-induced autologous chondrocyte implantation (MACI) for the treatment of patients with chondral defects of the knee.Technology Description: MACI is a multi-stage procedure that involves 2 surgeries. During an initial...
by TractManager | Aug 26, 2020 | News
The Food and Drug Administration (FDA) has announced a Class I recall of certain Smiths Medical Syringe Pumps due to a risk of medication delivery errors.Smiths Medical is recalling specific software versions of the Medfusion 3500 and 4000 Syringe Pumps because of a...
by TractManager | Aug 24, 2020 | COVID-News, News
On August 23, 2020, the Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for convalescent plasma for the treatment of COVID-19. Based on scientific evidence available, the FDA determined that it is reasonable to believe that COVID-19...
by TractManager | Aug 24, 2020 | Emerging Technology Report
Enspryng (satralizumab) is interleukin-6 (IL-6) receptor antagonist indicated for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive. It is administered by subcutaneous injection.If you...
by TractManager | Aug 19, 2020 | Health Technology Assessment
Focus of the Report: The use of deep brain stimulation (DBS) for treatment of refractory obsessive-compulsive disorder (OCD). Technology Description: DBS therapy uses mild electrical impulses to regulate electrical activity of neural circuits. Patients undergo surgery...
Recent Comments